Entry | Author | Date | Location | |
---|---|---|---|---|
Amicus’s Scioderm Deal Flops as Skin Drug Fails in Phase 3 | Ben Fidler | 09/13/17 | New York | |
With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher | Ben Fidler | 08/31/15 | New York | |
Orphan Drug From Scioderm Aims to Treat Rare Skin Disease | Frank Vinluan | 10/07/14 | Raleigh Durham | |
Page 1 of 1 | ||||